This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB07039/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07039/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07039/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07039/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07039
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07039 n13:DB07039
dcterms:title
(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
adms:identifier
n9:24892823 n10:99443510 n11:DB07039 n12:3B6
n3:IUPAC-Name
n4:271B43A8-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B43AE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B43AD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B43AA-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B43AB-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B43AC-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B43A6-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B43A4-363D-11E5-9242-09173F13E4C5 n4:271B43A7-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B43A5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B43B4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B43B5-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B43AF-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B43B0-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B43B2-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B43B1-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B43B3-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B43BA-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B43BC-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B43BD-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B43B9-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B43B8-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B43BB-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B43A9-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B43B6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B43B7-363D-11E5-9242-09173F13E4C5